Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.07. | iZafe Group Signs Agreement with AddSecure Smart Care Oy to launch Dosell in Finland | 236 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 9, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) has signed an agreement with AddSecure Smart Care Oy for the distribution of the medication dispenser... ► Artikel lesen | |
IZAFE GROUP Aktie jetzt für 0€ handeln | |||||
07.07. | iZafe Group: Monthly Update June - New Share Issue, Shareholder Campaign, and Continued International Growth | 212 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 7, 2025 / iZafe Group (STO:IZAFE-B) - Strong Start to the Summer - and Continued Focus on Reaching 10 MSEK in ARRJune was marked by strategic initiatives and a... ► Artikel lesen | |
27.06. | iZafe Group Resolves on a Directed Share Issue of Approximately SEK 10 million | 251 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 27, 2025 / iZafe Group (STO:IZAFE-B.ST) ("iZafe" or the "Company") announces today that the Board of Directors has resolved, based on the authorization granted... ► Artikel lesen | |
05.06. | iZafe Group: Monthly Update May - Surpassing 1,000 Units and Growing Strategic Partnerships | 249 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 5, 2025 / iZafe Group (STO:IZAFE-B) - May has been an eventful month where we took yet another important step forward. The number of active billable Dosell units... ► Artikel lesen | |
03.06. | iZafe Group: Dosell Reaches 1,000 Units in Operation - Celebrates Milestone with Investor Event in Stockholm | 236 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / June 3, 2025 / iZafe Group (STO:IZAFE-B) ("iZafe" or "the Company") today announces that its subsidiary Dosell has reached a significant milestone: more than 1... ► Artikel lesen | |
20.05. | iZafe Group: iZafe signs Letter of Intent with JDM Innovation with the Goal to Initiate a Strategic Partnership in Europe | 302 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 20, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) ("iZafe" or "the Company") today announces that it has signed a Letter of Intent (LOI) with German... ► Artikel lesen | |
08.05. | iZafe Group: April Monthly Report - Continued Growth as We Approach 1,000 Active Units | 192 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 8, 2025 / iZafe Group (STO:IZAFE-B) - April was a month marked by concrete expansion, deepened customer relationships, and sustained strong interest from new stakeholders.... ► Artikel lesen | |
25.04. | iZafe Group Q1 Interim Report, January-March 2025 | 249 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 25, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 25th, its report for the first quarter.Financial Performance in SummaryTotal... ► Artikel lesen | |
03.04. | iZafe Group: March Monthly Update - Continued Growth and Important Progress | 232 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 3, 2025 / iZafe Group (STO:IZAFE-B) - After an increase of billable Dosell units by 25% in January and an additional 9% in February, the number rose by another... ► Artikel lesen | |
21.03. | iZafe Group AB Changes Certified Adviser to Carnegie Investment Bank AB | 261 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / March 21, 2025 / iZafe Group (STO:IZAFE-B) (publ) announces today that the company is changing its Certified Adviser from Mangold Fondkommission AB to Carnegie... ► Artikel lesen | |
06.03. | Increased Demand and Successful Launch - iZafe Group Strengthens Its Position | 2.088 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 6, 2025 / iZafe Group (STO:IZAFE-B) February was an intense and forward-looking month for iZafe Group. We continue to accelerate our growth and strengthen our... ► Artikel lesen | |
27.02. | iZafe Group's Board Member Magnus Engman Purchases 200,000 Shares | 295 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / February 27, 2025 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Magnus Engman, acquired 200,000 B-shares in the company on February 26, at a total value of 52... ► Artikel lesen | |
24.02. | iZafe Group: Launch of Dosell Sales in Spain - A Groundbreaking Solution to Improve Medication Adherence | 321 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") proudly announces the sales launch of Dosell in Spain through a strategic partnership... ► Artikel lesen | |
14.02. | iZafe Group Q4 Interim Report, October-December 2024 and New Forecast | 257 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / February 14, 2025 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB (publ.) presents today, February 14, its report for the fourth quarter.Financial Performance in... ► Artikel lesen | |
06.02. | Strong Start to 2025 - iZafe Group Accelerates Dosell's Growth | 209 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / February 6, 2025 / iZafe Group (STO:IZAFE-B) 2025 has started on a positive note for iZafe Group, with steady growth in Dosell and increasing demand across multiple... ► Artikel lesen | |
20.12.24 | The Year in Review: Reflections from iZafe Group's CEO on 2024 | 313 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / December 20, 2024 / iZafe Group (STO:IZAFE-B) 2024 has been a transformative year for iZafe Group, where we have laid a strong foundation for the future. We have multiplied... ► Artikel lesen | |
06.12.24 | iZafe Group AB Strengthens Global Position with UMO Certification for Dosell | 372 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESSWIRE / December 6, 2024 / iZafe Group (STO:IZAFE-B) announces that its product, Dosell, is now certified for integration with Enovation UMO, the monitoring solution for medical... ► Artikel lesen | |
18.11.24 | iZafe Group: Dosell Secures Large Order for 1,000 Units in the Netherlands - Order Value of SEK 3 Million and Up to SEK 400,000/Month in Recurring Revenue | 361 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / November 18, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ) ("iZafe") announces today that it has received a new confirmed order for an additional 1,000 Dosell units... ► Artikel lesen | |
14.11.24 | iZafe Group's CFO, Marius Sandberg, Purchases 177,793 Shares | 249 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESSWIRE / November 14, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group's CFO, Marius Sandberg, has today acquired 177,793 B-shares in the company at a value of SEK 34,909 (SEK 0.196... ► Artikel lesen | |
01.11.24 | iZafe Group Q3 Interim Report, July-September 2024 | 450 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1, its report for the third quarter.Financial Performance in SummaryTotal revenue... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,110 | -1,03 % | BASF schraubt Erwartungen zurück, Brenntag wird ebenfalls vorsichtiger, Covestro reiht sich ein und Siemens Healthineers leidet unter Zollsorgen | Einmal mehr sorgt US-Präsident Donald Trump mit diversen Zolldrohungen für Verunsicherung an der Börse. Der EU werden ab August pauschal 30 Prozent für sämtliche Exporte in die USA in Aussicht gestellt... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,940 | -1,40 % | DAX tiefer, Bitcoin, Silber stark: BASF, Lufthansa, BMW, Rheinmetall, FMC, Siemens Energy ... | Die Ankündigung von Donald Trump, Importe aus der EU ab 1. August mit einem Zoll in Höhe von 30 Prozent belegen zu wollen, hat beim DAX am Freitag Bremsspuren hinterlassen. Der deutsche Leitindex verabschiedete... ► Artikel lesen | |
GERRESHEIMER | 47,140 | -0,13 % | EQS-News: Gerresheimer AG: Gerresheimer erreicht A- im CDP-Rating | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer erreicht A- im CDP-Rating
15.07.2025 / 10:00 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent... ► Artikel lesen | |
CARL ZEISS MEDITEC | 51,70 | +1,47 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Carl Zeiss Meditec vor der Quartalsbilanz mit einem Kursziel von 55 Euro auf "Hold" belassen. Der Medizintechnikhersteller... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 58,34 | -1,00 % | Procept BioRobotics: BofA bestätigt Kaufempfehlung trotz geplanter Medicare-Kürzungen | ||
RXSIGHT | 7,350 | -0,41 % | Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review | ||
UNITEDHEALTH | 242,95 | -0,10 % | Bank-Bilanzen im Fokus - Bitcoin, Nel, United Health, ASML, Goldman Sachs, BoA, Johnson & Johnson | Die Wall Street beendete den gestrigen Handelstag uneinheitlich. Während Standardwerte kaum gefragt waren, sorgte erneut der Technologiebereich für Bewegung. Der Nasdaq 100 stieg zur Eröffnung auf ein... ► Artikel lesen | |
ATRICURE | 29,260 | -1,65 % | AtriCure completes enrollment in stroke prevention trial | ||
GENEDX | 78,00 | -3,17 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
NUTEX HEALTH | 113,81 | +2,74 % | Nutex Health: Aktionäre wählen Vorstand und genehmigen Planänderungen auf Hauptversammlung | ||
DRAEGERWERK | 70,10 | +2,49 % | Draegerwerk AG & Co. KGaA: Q2-Vorläufige Ergebnisse: Starker Auftragseingang stützt Prognose für das Gesamtjahr. HALTEN | Die vorläufigen Ergebnisse von Dräger für das zweite Quartal 2025 zeigen einen stabilen Umsatz, eine starke Auftragsdynamik und entsprechen unseren Erwartungen. Der Umsatz stieg währungsbereinigt um... ► Artikel lesen | |
MIMEDX | 6,420 | -4,11 % | MiMedx Group, Inc: MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026 | MARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today commented on the Centers for Medicare and Medicaid Services ("CMS") release of... ► Artikel lesen | |
HIMS & HERS HEALTH | 43,220 | -0,25 % | Hims & Hers nach Aus mit Novo Nordisk: "Erhöhtes Risiko von Rechtsstreitigkeiten" | Wie gewonnen, so zerronnen: Zunächst entfachte die umfangreiche Zusammenarbeit zwischen dem Telehealth-Unternehmen Hims & Hers und dem Biopharma-Riesen Novo Nordisk jede Menge Euphorie. Doch dann kam... ► Artikel lesen | |
INCANNEX HEALTHCARE | 0,598 | +61,44 % | Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) | NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing... ► Artikel lesen |